Product overview
Vaccine type
Diphtheria-Tetanus-Pertussis (whole cell)
Commercial Name
None used on labelling for supply through UN agencies. Also marketed with labelled commercial name TRIPVAC
Manofacturer
Biological E. Limited
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 14
Secondary Packaging
Carton of 24 vials (240 doses)[Dimensions: 14.5 x 10.8 x 4.5 cm]
Tertiary Packaging
Box containing 32 cartons of 24 vials (7680 doses) [Dimensions:66 x 53 x 43 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01 % w/v
Cold Chain Volume
2.9 cm3/dose (in secondary packaging)
Attachments